A Randomised Control Trial Comparing the Efficacy of Platelet-Rich Plasma (PRP Therapy) and 5% Topical Minoxidil for the Treatment of Hair Loss (Androgenetic Alopecia). Sept 2023 Trial.
Journal of Drugs and Dermatology conducted a recent trial looking into the comparison of PRP treatment for hair loss.
Androgenetic alopecia (patern hair loss) is the most common cause of hair loss in men and women and has can be notoriously difficult to treat. Minoxidil is a common therapeutic option for hair patients because of its availability. Platelet-rich plasma (PRP therapy) is a relatively newer treatment option in hair loss with promising results, with great safety profile. This study objective was to compare the efficacy of PRP and minoxidil treatment for the treatment of hair loss in a Pakistani population. Patients were in this control trial and were either treated with PRP or topical scalp minoxidil. After 3 months of treatment hair follicle strength was examined.
This study reported a 91.7% negative hair pull rate in the PRP treatment group which was significantly greater than the 69.4% negative hair pull rate in the minoxidil-treated group, suggesting that PRP therapy can provide a higher efficacy compared to minoxidil for treating pattern hair loss. These results have further opportunity to improve patient compliance and overall satisfaction while offering an improved option in patients unsatisfied with topical minoxidil. Furthermore, PRP treatment has the advantage that it does not need to be used as frequent as minoxidil and longer term progress seen. When patients stop or fluctuate with minoxidil, this can cause increase shedding.
Study can be found here.
Get a FREE assessment today and find out what the best option for you and your hair loss.
Dynamic Regenerative Medicine